Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis

J Infect Dis. 1994 Sep;170(3):622-9. doi: 10.1093/infdis/170.3.622.

Abstract

Antibodies were raised in rabbits by immunization with the heat-killed J5 mutant of Escherichia coli O111 (Rc chemotype). Serum antibodies were separated into purified IgG and IgM by sequential affinity chromatography on protein G-Sepharose and anti-rabbit IgG-Sepharose columns. J5 lipopolysaccharide (LPS)-specific IgG was prepared by affinity chromatography of purified IgG on a J5 LPS-EAH Sepharose 4B affinity column. Purified IgM, IgG, and J5 LPS-specific IgG protected neutropenic rats against lethal challenge with Pseudomonas aeruginosa 12:4:4 (Fisher Devlin immunotype 6). Nine of 16 rats treated with the IgM fraction were protected (P < .001). Thirteen of 20 rats treated with the purified IgG and 6 of 8 treated with J5 LPS-specific IgG were protected compared with none of 25 treated with IgG made from the preimmune serum of the same rabbit (P < .001). These results demonstrate that purified J5 LPS-specific IgG protects against the lethal consequences of gram-negative bacteremia.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antibody Specificity
  • Bacteremia / immunology
  • Bacteremia / prevention & control*
  • Bacterial Vaccines / isolation & purification
  • Bacterial Vaccines / pharmacology*
  • Blotting, Western
  • Chromatography, Affinity
  • Enzyme-Linked Immunosorbent Assay
  • Escherichia coli / immunology*
  • Female
  • Immunodiffusion
  • Immunoglobulin G / isolation & purification
  • Immunoglobulin G / pharmacology*
  • Lipid A / immunology
  • Lipid A / isolation & purification
  • Lipopolysaccharides / immunology*
  • Lipopolysaccharides / isolation & purification
  • Neutropenia / immunology*
  • Pseudomonas Infections / immunology
  • Pseudomonas Infections / prevention & control*
  • Pseudomonas aeruginosa
  • Rabbits / immunology
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Bacterial Vaccines
  • Immunoglobulin G
  • Lipid A
  • Lipopolysaccharides